Acquisition of Sitagliptin

This tender, issued by HTAL. BRAULIO MOYANO, is for the acquisition of Sitagliptin, a medication used primarily for the management of type 2 diabetes. The procurement method is 'CONTRATACION MENOR' (Minor Contracting). The specific item required is Sitagliptin in tablet form, at a dosage of 50 mg, with a quantity of 1,200 units. This medication is essential for patients requiring glycemic control. The tender falls under the 'Salud' (Health) category. The estimated cost for the 1,200 units is ARS 2,935.0. The 'Minor Contracting' method is employed, indicating a straightforward and efficient process for procuring this vital pharmaceutical for patient treatment.

This is a works contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Argentina, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of ARS 3.5 million.

Published through Buenos Aires Compras (BAC), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for civil works in the health and medical services sector. Works contracts of this nature generally require demonstrated experience in similar infrastructure projects, adequate equipment and technical personnel, and financial capacity including bank guarantees. This contract has already been awarded. The information is published for transparency and market intelligence purposes.